Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/301201 stock hub

SHE/301201 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301201is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301201

In the news

Latest news · SHE/301201

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/En/a

P25 23.5P50 41.3P75 83.2

ROE-0.2

P25 -0.9P50 4.1P75 8.8

ROIC2.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301201 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

CNY

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	656
Employees Change	49%
Employees Change Percent	8.07
Enterprise value	CNY 5.4B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100005766
Last refreshed	2026-05-10
Market cap	CNY 6.3B
Price	CNY 41.84
Price currency	CNY
Rev Per Employee	755,031.44x
Sector	Healthcare
Sic	2833
Symbol	she/301201
Website	https://www.chengdapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.06%
EV Earnings	-1,542.36x
EV/EBIT	224.17x
EV/EBITDA	52.39x
EV/FCF	-430.49x
EV/Sales	11.86x
FCF yield	-0.2%
P/B ratio	3.01x
P/S ratio	13.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.29%
EBITDA Margin	22.63%
Gross margin	40.43%
Gross Profit	CNY 185.3M
Gross Profit Growth	34.12%
Gross Profit Growth Q	15.84%
Gross Profit Growth3 Y	4.13%
Gross Profit Growth5 Y	7.02%
Net Income	CNY -3.5M
Pretax Margin	-0.52%
Profit Margin	-0.77%
Profit Per Employee	CNY -5,805
ROA	0.64
Roa5y	2.9
ROCE	1.12
ROE	-0.17
Roe5y	6.06
ROIC	2.06
Roic5y	5.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	95.13%
Cagr3y	16.12%
Div CAGR3	-12.64%
OCF Growth3 Y	-24.79%
OCF Growth5 Y	-7.56%
Revenue Growth	48.54x
Revenue Growth Q	68.06x
Revenue Growth3 Y	4.2x
Revenue Growth5 Y	9.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.19
Assets	CNY 2.3B
Cash	CNY 964.1M
Current Assets	CNY 1.3B
Current Liabilities	CNY 171.8M
Debt	CNY 59.1M
Debt EBITDA	CNY 0.57
Debt Equity	CNY 0.03
Debt FCF	CNY -4.68
Equity	CNY 2.1B
Liabilities	CNY 228.1M
Long Term Assets	CNY 1B
Long Term Liabilities	CNY 56.4M
Net Cash	CNY 905M
Net Cash By Market Cap	CNY 14.28
Net Cash Growth	-9.72%
Net Debt EBITDA	CNY -8.72
Net Debt Equity	CNY -0.43
Tangible Book Value	CNY 2.1B
Tangible Book Value Per Share	CNY 13.62
WACC	3.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.57
Inventory Turnover	1.99
Net Working Capital	CNY 179.9M
Quick ratio	6.44
Working Capital	CNY 1.1B
Working Capital Turnover	CNY 0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.19%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.2
Dividend Years	4
Dividend Yield	0.48%
Ex Div Date	2025-07-10
Last Dividend	CNY 0.2
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	95.04%
200-day SMA	37.89
3Y total return	56.61%
50-day SMA	44.61
50-day SMA vs 200-day SMA	50over200
All Time High	117.5
All Time High Change	-64.39%
All Time High Date	2022-01-20
All Time Low	14.6
All Time Low Change	186.58%
All Time Low Date	2024-02-06
ATR	2.39
Beta	-0.18
Beta1y	-0.51
Beta2y	-0.03
Ch YTD	2.8
High	42.32
High52	65.03
High52 Date	2026-04-07
High52ch	-35.66%
Low	41.11
Low52	20.31
Low52 Date	2025-06-23
Low52ch	106.01%
Ma50ch	-6.21%
Price vs 200-day SMA	10.44%
RSI	44.26
RSI Monthly	58.68
RSI Weekly	50.76
Sharpe ratio	1.23x
Sortino ratio	2.15
Total Return	0.67%
Tr YTD	2.8
Tr1m	-33.03%
Tr1w	1.11%
Tr3m	9.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 24.2M
Operating Income Growth3 Y	-23.52
Operating Income Growth5 Y	-18.06
Operating margin	5.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	71,179,583%
Net Borrowing	-29,132,485
Shares Insiders	40.64%
Shares Institutions	0.06%
Shares Out	151,469,124
Shares Qo Q	-0.01%
Shares Yo Y	-0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -12.6M
Average Volume	10,235,542x
Bv Per Share	13.87
CAPEX	CNY -58.2M
Ch1m	-33.03
Ch1w	1.11
Ch1y	93.35
Ch3m	9.96
Ch3y	52.42
Ch6m	34.58
Change	0.5%
Change From Open	0.41
Close	41.63
Days Gap	0.1
Depreciation Amortization	79,491,994
Dollar Volume	242,416,776
Earnings Date	2026-04-28
EBIT	CNY 24.2M
EBITDA	CNY 103.7M
EPS	CNY -0.02
F Score	5
FCF	CNY -12.6M
FCF EV Yield	-0.23x
FCF Per Share	CNY -0.08
Financing CF	-61,746,965
Fiscal Year End	December
Founded	1,980
Income Tax	CNY 1.2M
Investing CF	-23,010,078
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2023-07-07
Last Split Type	Forward
Ma150	41.19
Ma150ch	1.57%
Ma20	43.57
Ma20ch	-3.96%
Net CF	-39,413,141
Next Earnings Date	2026-08-28
Open	41.67
P OCF Ratio	139.1
Payment Date	2025-07-10
Position In Range	60.33
Ppne	821,150,944
Price Date	2026-05-08
Price EBITDA	CNY 61.09
Ptbv Ratio	3.07
Relative Volume	0.57x
Revenue	458,304,083x
Tax By Revenue	0.27x
Tr6m	34.58%
Volume	5,793,900

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301201 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.20 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2025-07-10

Performance

SHE/301201 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301201?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+40.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

SHE/301201 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.3

Neutral momentum band

Price vs 200-day MA

+10.4%

50/200-day relationship not available

Beta (5Y)

-0.18

Less volatile than the market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301201

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301201 stock rating?

she/301201 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301201 analysis?

The full report lives at /stocks/she/301201/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301201?

The latest report frames she/301201 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301201 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.